Icecure Medical Other Operating Expenses Over Time
| ICCM Stock | USD 0.71 0.11 18.33% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Icecure Medical Performance and Icecure Medical Correlation. Icecure |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Icecure Medical. If investors know Icecure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Icecure Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.29) | Revenue Per Share 0.071 | Quarterly Revenue Growth 0.079 | Return On Assets (0.47) | Return On Equity (0.94) |
The market value of Icecure Medical is measured differently than its book value, which is the value of Icecure that is recorded on the company's balance sheet. Investors also form their own opinion of Icecure Medical's value that differs from its market value or its book value, called intrinsic value, which is Icecure Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Icecure Medical's market value can be influenced by many factors that don't directly affect Icecure Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Icecure Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Icecure Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Icecure Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Operating Expenses Analysis
Compare Icecure Medical and related stocks such as BrainsWay, ProSomnus, Common Stock, and SurModics Other Operating Expenses Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SRDX | 8.8 M | 35.6 M | 36.8 M | 38.9 M | 42.8 M | 49.8 M | 66.1 M | 81.6 M | 92.9 M | 96.1 M | 97.4 M | 122 M | 127 M | 131.7 M | 138.3 M |
| SSKN | 2 M | 20.5 M | 23 M | 23.7 M | 17.5 M | 35 M | 35.4 M | 33.9 M | 33.2 M | 33.2 M | 27.2 M | 34.4 M | 40.8 M | 39.7 M | 22.8 M |
| TNON | 587.1 K | 587.1 K | 587.1 K | 587.1 K | 587.1 K | 587.1 K | 587.1 K | 587.1 K | 587.1 K | 587.1 K | 580.1 K | 6.6 M | 19.4 M | 18.7 M | 10.1 M |
| BWAY | 6 M | 6 M | 6 M | 5.5 M | 10.7 M | 11.3 M | 13.6 M | 17.8 M | 21.5 M | 31.6 M | 26.9 M | 34.7 M | 39.9 M | 36.7 M | 23.5 M |
| SINT | 36.3 M | 36.3 M | 36.9 M | 32.6 M | 46.9 M | 31.5 M | 26.8 M | 26.8 M | 7.7 M | 7.3 M | 10.3 M | 11.2 M | 11.9 M | 16 M | 18.6 M |
| CTSO | 90 K | 4.5 M | 3.6 M | 5.5 M | 10.4 M | 13.4 M | 19.7 M | 23.2 M | 35.8 M | 41.7 M | 49.8 M | 62.9 M | 60.9 M | 67.6 M | 70.9 M |
| NPCE | 59 M | 59 M | 59 M | 59 M | 59 M | 59 M | 59 M | 59 M | 59 M | 59 M | 54.2 M | 68.9 M | 86.3 M | 92.6 M | 79.4 M |
| CLPT | 10.4 M | 9.7 M | 8.2 M | 11.4 M | 13.3 M | 12.3 M | 13.2 M | 13.7 M | 12.6 M | 15.8 M | 19 M | 29.7 M | 36.9 M | 46.4 M | 48.7 M |
| TELA | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 21.2 M | 28.2 M | 34.6 M | 43.5 M | 58.9 M | 80.4 M | 102.5 M | 58 M |
| KIDS | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 37.6 M | 43.4 M | 52.1 M | 67.1 M | 81.6 M | 91.5 M | 115.9 M | 144.1 M | 174.5 M | 92.3 M |
| CNMD | 9.1 M | 656.5 M | 701.9 M | 700.2 M | 681.7 M | 668 M | 725.8 M | 749.5 M | 788.3 M | 876 M | 816.4 M | 900.9 M | 975.4 M | 1.1 B | 1.2 B |
| ITGR | 66.8 M | 507.1 M | 620.4 M | 602.6 M | 612.1 M | 787.3 M | 1.3 B | 1.3 B | 1.1 B | 1.1 B | 952.8 M | 1.1 B | 1.2 B | 1.4 B | 1.5 B |
| SGHT | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 21.8 M | 47.4 M | 59.8 M | 100.4 M | 155.3 M | 138.3 M | 95.9 M |
| TMCI | 43 M | 43 M | 43 M | 43 M | 43 M | 43 M | 43 M | 43 M | 43 M | 43 M | 56.5 M | 110.9 M | 176.7 M | 238.5 M | 137.6 M |
| ESTA | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 35.6 M | 54.7 M | 85.1 M | 120.5 M | 112.6 M | 151.8 M | 201.4 M | 230.2 M | 136.4 M |
Icecure Medical and related stocks such as BrainsWay, ProSomnus, Common Stock, and SurModics Other Operating Expenses description
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Icecure Medical. It is also known as Icecure Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.My Equities
My Current Equities and Potential Positions
| Icecure Medical | ICCM |
Specialization | Health Care, Health Care Equipment & Services |
| Location | Israel |
| Exchange | NASDAQ Exchange |
USD 0.71
Check out Icecure Medical Performance and Icecure Medical Correlation. To learn how to invest in Icecure Stock, please use our How to Invest in Icecure Medical guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Icecure Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.